KRAS and neoplasm: The KRAS G12/G13 kit we used allowed for the detection of all the frequent mutations encountered in exon 2 of the gene (G12A, G12C, G12D, G12R, G12S, G12V, and G13D), and thus any of these mutations in the same tumor sample, can contribute towards classification of the sample as being mutation positive.